These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24830425)
1. Immune humanization of immunodeficient mice using diagnostic bone marrow aspirates from carcinoma patients. Werner-Klein M; Proske J; Werno C; Schneider K; Hofmann HS; Rack B; Buchholz S; Ganzer R; Blana A; Seelbach-Göbel B; Nitsche U; Männel DN; Klein CA PLoS One; 2014; 9(5):e97860. PubMed ID: 24830425 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficiency of human immune system reconstitution in NSG mice and NSG mice containing a human HLA.A2 transgene using hematopoietic stem cells purified from different sources. Patton J; Vuyyuru R; Siglin A; Root M; Manser T J Immunol Methods; 2015 Jul; 422():13-21. PubMed ID: 25776756 [TBL] [Abstract][Full Text] [Related]
3. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer. Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714 [TBL] [Abstract][Full Text] [Related]
4. Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses. Chung YS; Son JK; Choi B; Joo SY; Lee YS; Park JB; Moon H; Kim TJ; Kim SH; Hong S; Chang J; Kang MS; Kim SJ Clin Immunol; 2015 Apr; 157(2):156-65. PubMed ID: 25725428 [TBL] [Abstract][Full Text] [Related]
5. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source. Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE Front Immunol; 2020; 11():573406. PubMed ID: 33193358 [TBL] [Abstract][Full Text] [Related]
6. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency. Tuckett AZ; Thornton RH; O'Reilly RJ; van den Brink MRM; Zakrzewski JL J Hematol Oncol; 2017 May; 10(1):109. PubMed ID: 28511686 [TBL] [Abstract][Full Text] [Related]
7. Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic stem cells. Wan X; Sato H; Miyaji H; McDaniel JM; Wang Y; Kaneko E; Gibson B; Mehta-D'Souza P; Chen Y; Dozmorov M; Miller LP; Goodman J; Sun Z; Xia L Glycobiology; 2013 Oct; 23(10):1184-91. PubMed ID: 23899669 [TBL] [Abstract][Full Text] [Related]
8. Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies. Wege AK; Schmidt M; Ueberham E; Ponnath M; Ortmann O; Brockhoff G; Lehmann J MAbs; 2014; 6(4):968-77. PubMed ID: 24870377 [TBL] [Abstract][Full Text] [Related]
9. Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer. Morton JJ; Keysar SB; Perrenoud L; Chimed TS; Reisinger J; Jackson B; Le PN; Nieto C; Gomez K; Miller B; Gao D; Somerset H; Wang XJ; Jimeno A Mol Carcinog; 2018 Nov; 57(11):1651-1663. PubMed ID: 30129680 [TBL] [Abstract][Full Text] [Related]
10. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents. Verma B; Wesa A Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514 [TBL] [Abstract][Full Text] [Related]
11. Hematological Humanization of Immune-Deficient Mice. Gergues M; Ayer S; Morelli S; Greco SJ; Rameshwar P Methods Mol Biol; 2021; 2224():195-202. PubMed ID: 33606216 [TBL] [Abstract][Full Text] [Related]
12. Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34 O'Brien LJ; Walpole CM; Leal-Rojas IM; Shatunova S; Moore A; Winkler IG; Guillerey C; Radford KJ Exp Hematol; 2024 Feb; 130():104134. PubMed ID: 38052261 [TBL] [Abstract][Full Text] [Related]
13. Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model study. Shafiee A; McGovern JA; Lahr CA; Meinert C; Moi D; Wagner F; Landgraf M; De-Juan-Pardo E; Mazzieri R; Hutmacher DW Int J Cancer; 2018 Sep; 143(6):1470-1482. PubMed ID: 29659011 [TBL] [Abstract][Full Text] [Related]
14. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses. Singh M; Singh P; Gaudray G; Musumeci L; Thielen C; Vaira D; Vandergeeten C; Delacroix L; Van Gulck E; Vanham G; de Leval L; Rahmouni S; Moutschen M PLoS One; 2012; 7(6):e38491. PubMed ID: 22675567 [TBL] [Abstract][Full Text] [Related]
16. Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells. Covassin L; Jangalwe S; Jouvet N; Laning J; Burzenski L; Shultz LD; Brehm MA Clin Exp Immunol; 2013 Dec; 174(3):372-88. PubMed ID: 23869841 [TBL] [Abstract][Full Text] [Related]
17. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors. Pilarski LM; Belch AR Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689 [TBL] [Abstract][Full Text] [Related]
18. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Kollet O; Spiegel A; Peled A; Petit I; Byk T; Hershkoviz R; Guetta E; Barkai G; Nagler A; Lapidot T Blood; 2001 May; 97(10):3283-91. PubMed ID: 11342460 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived human hematopoietic stem cells engraft NOD/SCID mice and traffic appropriately to an inflammatory stimulus in the joint. Chang NH; Inman RD; Dick JE; Wither JE J Rheumatol; 2010 Mar; 37(3):496-502. PubMed ID: 20110518 [TBL] [Abstract][Full Text] [Related]